Related Experiment Video
Updated: May 11, 2026
08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Functionalized superparamagnetic nanoparticles for highly-efficient gene delivery.
Xiaowen Wang1, Benke Chen, Xin Yang
1Institute of Neurological Disorders, Yuquan Hospital, Tsinghua University, China, Beijing 100049, China.
Journal of Nanoscience and Nanotechnology
|May 8, 2013
Summary
Modified superparamagnetic iron oxide nanoparticles (SPIONs) with protamine enhance cellular uptake and gene transfection efficiency. These protamine-modified SPIONs show promise for combined cancer hyperthermia and gene therapy applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Gene Therapy
Background:
- Superparamagnetic iron oxide nanoparticles (SPIONs) are vital for medical applications including cancer hyperthermia, MRI, and magnetofection.
- Gene therapy offers revolutionary potential for treating human diseases.
Purpose of the Study:
- To develop and evaluate modified magnetic nanoparticles for enhanced gene delivery.
- To investigate the efficacy of protamine-coated SPIONs for gene therapy applications.
Main Methods:
- SPIONs were functionalized with protamine, incorporating nuclear localization signal sequences.
- Characterization included thermogravimetric analysis and X-ray powder diffraction.
- Cellular uptake and gene magnetofection efficiency were assessed in HepG2 cells.
Main Results:
- Protamine modification significantly increased cellular uptake of SPIONs.
- Enhanced SPIONs demonstrated higher gene transfection efficiency in HepG2 cells.
- The modified SPIONs proved effective as magnetic mediators.
Conclusions:
- Protamine-modified SPIONs represent a novel and highly efficient magnetic mediator for biomedical applications.
- These nanoparticles show significant potential for combined magnetic induction hyperthermia and gene therapy.
- The study highlights the utility of functionalized SPIONs in advancing gene therapy delivery systems.
